Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
The provision of a live attenuated intranasal influenza vaccine, to be used to support the annual seasonal influenza vaccination programme, which includes children. The volume requirement is 3,364,470 doses of vaccine.
Value - this information is considered by the supplier to be commercially sensitive information. The authority is not publishing the value so as not to prejudice the legitimate commercial interest of the supplier.
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| AstraZeneca | 03674842 | £1 | LOBBYIST FTI Consulting LLP (6 quarters) Incisive Health Ltd (6 quarters) Teneo Strategy Limited (3 quarters) Hanover Communications International Limited (2 quarters) MHP Communications (1 quarter) |
Government spending data: This supplier has received £201,701,630 in 43 payments (over £25k) from UK Health Security Agency, Department of Health and Social Care (2020-06-29 to 2026-03-05). View full payment history →